ConductScience.org, home

Paper41555342

ESM1 and protein lysine L-lactylation modification (Pan-kla) in ovarian cancer: coexpression, clinical significance, and prognostic value.

Zhou W and 6 others. Diagn Pathol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. ESM1 and protein lysine L-lactylation modification (Pan-kla) in ovarian cancer: coexpression, clinical significance, and prognostic value. Papers, record 41555342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41555342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ESM1 and protein lysine L-lactylation modification (Pan-kla) in ovarian cancer: coexpression, clinical significance, and prognostic value.
PubMed
Journal
Diagn Pathol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-06-28
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhou WWenchao
2Zhou YYang
3Zeng TTian
4Gao ZZhenqin
5Deng YYi
6Li YYukun
7Quan XXiyun

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ovarian NeoplasmsMajor topic
Biomarkers, TumorMajor topic
Neoplasm ProteinsMajor topic
Humans
Female
Prognosis
Middle Aged
Aged
Adult
Tumor Microenvironment
Immunohistochemistry
Lysine
Proteoglycans

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82303246the Natural Science Foundation of ChinaPubMed
2025JJ50493the Natural Science Foundation of Hunan ProvincePubMed
W20243173Health Research Project of Hunan Provincial Health CommissionPubMed

Source PubMed

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139281564The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells.Heliyon2024https://conductscience.org/library/papers/39281564PubMed
238897128Lactate drives the ESM1-SCD1 axis to inhibit the antitumor CD8+ T-cell response by activating the Wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance.Int Immunopharmacol2024https://conductscience.org/library/papers/38897128PubMed
339545414Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation.J Clin Invest2024https://conductscience.org/library/papers/39545414PubMed
440132584Lactylation of LSD1 is an acquired epigenetic vulnerability of BRAFi/MEKi-resistant melanoma.Dev Cell2025https://conductscience.org/library/papers/40132584PubMed
538212795ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1.J Transl Med2024https://conductscience.org/library/papers/38212795PubMed
639929852ESM1 promote proliferation, invasion and angiogenesis via Akt/mTOR and Ras pathway in kidney renal clear cell carcinoma.Sci Rep2025https://conductscience.org/library/papers/39929852PubMed
740089962ESM1 suppresses LncRNA GAS5/miR-23a-3p/PTEN axis to promote the cisplatin-chemotherapy resistance of ovarian cancer cells via activating the PI3K/AKT pathway.Discov Oncol2025https://conductscience.org/library/papers/40089962PubMed
840073846Lactate: A key regulator of the immune response.Immunity2025https://conductscience.org/library/papers/40073846PubMed
940030031Dynamic investigation of hypoxia-induced L-lactylation.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40030031PubMed
1037653142Clinical and translational advances in ovarian cancer therapy.Nat Cancer2023https://conductscience.org/library/papers/37653142PubMed
1136605187Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.Front Immunol2022https://conductscience.org/library/papers/36605187PubMed
1236593272Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.Nat Metab2023https://conductscience.org/library/papers/36593272PubMed
1338653238Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis.Cell2024https://conductscience.org/library/papers/38653238PubMed
1436594088Validation of ESM1 Related to Ovarian Cancer and the Biological Function and Prognostic Significance.Int J Biol Sci2023https://conductscience.org/library/papers/36594088PubMed
1540320451Unveiling the protective role of ESM1 in endothelial cell proliferation and lipid reprogramming.Sci Rep2025https://conductscience.org/library/papers/40320451PubMed
1640314877Lactic acid metabolism: gynecological cancer's Achilles' heel.Discov Oncol2025https://conductscience.org/library/papers/40314877PubMed
1727189072Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3N.Diagn Pathol2016https://conductscience.org/library/papers/27189072PubMed
1821435938Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review.Drug Resist Updat2011https://conductscience.org/library/papers/21435938PubMed
1939642882Nuclear GTPSCS functions as a lactyl-CoA synthetase to promote histone lactylation and gliomagenesis.Cell Metab2025https://conductscience.org/library/papers/39642882PubMed
2040113760Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis.Cell Death Dis2025https://conductscience.org/library/papers/40113760PubMed

See all 25 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42780579Research progress on protein lactylation in female reproductive disease: molecular mechanisms, functions, and therapeutic implications.Front Pharmacol2026https://conductscience.org/library/papers/42780579

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ESM111082PubTator's text mininghttps://conductscience.org/library/genes/11082

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41555342

GET https://conductscience.org/api/papers/v1/41555342/references?page=2